Erratum: Early onset HER2-positive breast cancer is associated with germline TP53 mutations (Cancer DOI: 10.1002/cncr.26377)

A. Melhem-Bertrandt; J. Bojadzieva; K. J. Ready; E. Obeid; D. D. Liu; A. M. Gutierrez-Barrera; J. K. Litton; O. I. Olopade; G. N. Hortobagyi; Louise C Strong; B. K. Arun

doi:10.1002/cncr.26534

Erratum: Early onset HER2-positive breast cancer is associated with germline TP53 mutations (Cancer DOI: 10.1002/cncr.26377)

A. Melhem-Bertrandt, J. Bojadzieva, K. J. Ready, E. Obeid, D. D. Liu, A. M. Gutierrez-Barrera, J. K. Litton, O. I. Olopade, G. N. Hortobagyi, Louise C Strong, B. K. Arun

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2561
Number of pages	1
Journal	Cancer
Volume	118
Issue number	9
DOIs	https://doi.org/10.1002/cncr.26534
State	Published - May 1 2012

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.26534

Cite this

Melhem-Bertrandt, A., Bojadzieva, J., Ready, K. J., Obeid, E., Liu, D. D., Gutierrez-Barrera, A. M., Litton, J. K., Olopade, O. I., Hortobagyi, G. N., Strong, L. C., & Arun, B. K. (2012). Erratum: Early onset HER2-positive breast cancer is associated with germline TP53 mutations (Cancer DOI: 10.1002/cncr.26377). Cancer, 118(9), 2561. https://doi.org/10.1002/cncr.26534

@article{a899babd275546898d8c633634d3f35f,

title = "Erratum: Early onset HER2-positive breast cancer is associated with germline TP53 mutations (Cancer DOI: 10.1002/cncr.26377)",

author = "A. Melhem-Bertrandt and J. Bojadzieva and Ready, {K. J.} and E. Obeid and Liu, {D. D.} and Gutierrez-Barrera, {A. M.} and Litton, {J. K.} and Olopade, {O. I.} and Hortobagyi, {G. N.} and Strong, {Louise C} and Arun, {B. K.}",

year = "2012",

month = may,

day = "1",

doi = "10.1002/cncr.26534",

language = "English (US)",

volume = "118",

pages = "2561",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

TY - JOUR

T1 - Erratum

T2 - Early onset HER2-positive breast cancer is associated with germline TP53 mutations (Cancer DOI: 10.1002/cncr.26377)

AU - Melhem-Bertrandt, A.

AU - Bojadzieva, J.

AU - Ready, K. J.

AU - Obeid, E.

AU - Liu, D. D.

AU - Gutierrez-Barrera, A. M.

AU - Litton, J. K.

AU - Olopade, O. I.

AU - Hortobagyi, G. N.

AU - Strong, Louise C

AU - Arun, B. K.

PY - 2012/5/1

Y1 - 2012/5/1

UR - http://www.scopus.com/inward/record.url?scp=84860183246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860183246&partnerID=8YFLogxK

U2 - 10.1002/cncr.26534

DO - 10.1002/cncr.26534

M3 - Comment/debate

AN - SCOPUS:84860183246

SN - 0008-543X

VL - 118

SP - 2561

JO - Cancer

JF - Cancer

IS - 9

ER -

Erratum: Early onset HER2-positive breast cancer is associated with germline TP53 mutations (Cancer DOI: 10.1002/cncr.26377)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this